echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: Long-term follow-up comparison between acute functional pseudo-stroke and mild acute ischemic stroke

    JNNP: Long-term follow-up comparison between acute functional pseudo-stroke and mild acute ischemic stroke

    • Last Update: 2021-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Every year, many patients are admitted to the emergency room for suspected acute ischemic stroke (AIS)


    Therefore, this article compares the long-term prognosis of patients with FSM and patients with mild AIS


    This single-center retrospective cohort study was conducted at the University Medical Center of Groningen


    This single-center retrospective cohort study was conducted at the University Medical Center of Groningen


    Participants used the Clinical Global Impression Improvement (CGI-I) Scale and CGI Severity (CGI-S) Scale to score their changes in symptoms and the severity of symptoms at admission and follow-up


    116 patients agreed to participate, of which 38 patients were diagnosed with FSM and 78 patients were diagnosed with mild AIS


    A) Clinical overall impression improvement scale (B) Clinical overall impression severity scale

    At follow-up, FSM patients scored significantly lower in several sub-areas of RAND-36: social function (median 56 (IQR 50-75) vs 75 (IQR 63-88); p=0.


    During follow-up, FSM patients scored significantly lower in several sub-areas of RAND-36: During follow-up, FSM patients scored significantly lower in several sub-areas of RAND-36:

    Compared with patients with mild AIS, the self-evaluated long-term prognosis of FSM patients is worse


    Compared with patients with mild AIS, the self-evaluated long-term prognosis of FSM patients is worse


    Given that 80% of FSM patients have persistent symptoms and have a significant impact on the quality of life, it can be considered that the prognosis of FSM is poor


    Given that 80% of FSM patients have persistent symptoms and have a significant impact on the quality of life, it can be considered that the prognosis of FSM is poor




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.